Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bobby Gaspar currently holds 366,158 shares of Orchard Therapeutics plc (ORTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bobby Gaspar has been a net seller of ORTX stock. They have purchased $11.1K and sold $64.0K worth of shares.
Bobby Gaspar's most recent insider trade was on Jan 24, 2024, when they sold 200,000 shares at $0.00 per share.
Bobby Gaspar serves as Executive at Orchard Therapeutics plc (ORTX). They have executed 18 insider transactions totaling $75.1K over their tenure at the company.
Bobby Gaspar holds the position of Executive at Orchard Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Bobby Gaspar has shown a selling trading pattern, with $11.1K in total purchases and $64.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bobby Gaspar was on Mar 2, 2020, when they sold $64.0K worth of ORTX shares. This transaction involved 4,921 shares at $13.00 per share.
Bobby Gaspar currently owns 366,158 shares of Orchard Therapeutics plc (ORTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bobby Gaspar's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bobby Gaspar has 18 Form 4 filings on record as an insider at Orchard Therapeutics plc.
Set alerts for Bobby Gaspar and 40,000+ other insiders.